1-7 of 7
Kathleen M. McCarten
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluating CHIPS in Pediatric High Risk Hodgkin Lymphoma Treated on AHOD1331

Cindy L Schwartz, Qinglin Pei, Frank G. Keller, Steve Y Cho, David C. Hodgson, Kathleen M McCarten, Yue Wu, Kara M. Kelly, Sharon M. Castellino
Journal: Blood
Blood (2022) 140 (Supplement 1): 6565–6566.
https://doi.org/10.1182/blood-2022-167188
Published: 2022
Journal Articles

Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis

Clinical Trials & Observations
Akash Parekh, Frank G. Keller, Kathleen M. McCarten, Sandy Kessel, Steve Cho, Qinglin Pei, Yue Wu, Sharon M. Castellino, Louis S. Constine, Cindy L. Schwartz, David Hodgson, Kara M. Kelly, Bradford S. Hoppe
Journal: Blood
Blood (2022) 140 (10): 1086–1093.
https://doi.org/10.1182/blood.2022016098
Published: 2022
Includes: Supplemental data
Journal Articles

Pericardial effusion in Hodgkin lymphoma: a report from the Children’s Oncology Group AHOD0031 protocol

Clinical Trials & Observations
Lianna J. Marks, Kathleen M. McCarten, Qinglin Pei, Debra L. Friedman, Cindy L. Schwartz, Kara M. Kelly
Journal: Blood
Blood (2018) 132 (11): 1208–1211.
https://doi.org/10.1182/blood-2018-02-834465
Published: 2018
Journal Articles

Changes in Serum TARC Predict PET Response Among Pediatric Patients with Relapsed or Refractory Hodgkin Lymphoma Treated with Brentuximab Vedotin and Gemcitabine: A Report from the Children's Oncology Group

Peter D Cole, MD, Menachem Spira, MD, Kathleen M McCarten, MD, Terzah M Horton, MD, Quinglin Pei, PhD, Monika Metzger, Richard A Drachtman, MD, Kara M. Kelly, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2798.
https://doi.org/10.1182/blood.V130.Suppl_1.2798.2798
Published: 2017
Journal Articles

18 f-FDG (FDG) PET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL). A Preliminary Retrospective Analysis of Children's Oncology Group (COG) AHOD0031

Steve Y Cho, MD, Kathleen M McCarten, MD, Lu Chen, PhD, Debra L Friedman, MD, MS, Suzanne L Wolden, MD, Kathryn Karolczuk, Cindy L Schwartz, MD, MPH, Kara M Kelly, MD
Journal: Blood
Blood (2012) 120 (21): 1530.
https://doi.org/10.1182/blood.V120.21.1530.1530
Published: 2012
Journal Articles

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

Debra l Friedman, MD, MS, Suzanne Wolden, Louis Constine, MD, Lu Chen, PhD, Kathleen M McCarten, MD, T. J Fitzgerald, Pedro De Alarcon, MD, Allen R. Chen, MD, PhD, MHS, Robert Hutchison, MD, Peter Ehrlich, Nathan L. Kobrinsky, MD, FRCP, Meghan Higman, Shirley Hogan, Lorna Roll, Tanya Trippett, Cindy Schwartz, MD
Journal: Blood
Blood (2010) 116 (21): 766.
https://doi.org/10.1182/blood.V116.21.766.766
Published: 2010
Journal Articles

A Phase III Study for the Treatment of Children and Adolescents with Newly Diagnosed Low Risk Hodgkin Lymphoma (HL)

Frank G Keller, MD, James Nachman, MD, Louis Constine, MD, John Thomson, MD, Kathleen M McCarten, MD, Lu Chen, PhD, Cindy Schwartz, MD
Journal: Blood
Blood (2010) 116 (21): 767.
https://doi.org/10.1182/blood.V116.21.767.767
Published: 2010